Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,402 | 151 | 99.6% |
| Education | $13.89 | 1 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Actelion Pharmaceuticals US, Inc. | $500.87 | 14 | $0 (2023) |
| Merck Sharp & Dohme LLC | $445.40 | 21 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $381.92 | 16 | $0 (2024) |
| United Therapeutics Corporation | $268.13 | 10 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $236.57 | 17 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $205.68 | 11 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $196.85 | 11 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $183.66 | 9 | $0 (2024) |
| Alnylam Pharmaceuticals Inc. | $171.25 | 7 | $0 (2024) |
| Ancora Heart, Inc. | $140.69 | 8 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,038 | 44 | Merck Sharp & Dohme LLC ($264.02) |
| 2023 | $1,377 | 71 | United Therapeutics Corporation ($163.92) |
| 2022 | $1,001 | 37 | Actelion Pharmaceuticals US, Inc. ($487.02) |
All Payment Transactions
152 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/03/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.64 | General |
| Category: DIABETES | ||||||
| 11/19/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $14.01 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/13/2024 | Bayer Healthcare Pharmaceuticals Inc. | Adempas (Drug), Kerendia | Food and Beverage | In-kind items and services | $20.16 | General |
| Category: Cardio-pulmonary | ||||||
| 11/12/2024 | Alnylam Pharmaceuticals Inc. | AMVUTTRA (Drug) | Food and Beverage | In-kind items and services | $31.71 | General |
| Category: Genetic Disease | ||||||
| 10/28/2024 | Ancora Heart, Inc. | AccuCinch (Device) | Food and Beverage | Cash or cash equivalent | $25.18 | General |
| Category: Cardiovascular | ||||||
| 10/24/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $22.17 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/23/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $31.04 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/08/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $16.04 | General |
| Category: Heart Failure and Hypertension | ||||||
| 10/01/2024 | AstraZeneca Pharmaceuticals LP | WAINUA (Drug) | Food and Beverage | In-kind items and services | $22.91 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/19/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $17.76 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/12/2024 | AstraZeneca Pharmaceuticals LP | WAINUA (Drug) | Food and Beverage | In-kind items and services | $18.01 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/11/2024 | Bayer Healthcare Pharmaceuticals Inc. | Adempas (Drug) | Food and Beverage | In-kind items and services | $21.73 | General |
| Category: Cardio-pulmonary | ||||||
| 09/03/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $15.45 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/30/2024 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Food and Beverage | In-kind items and services | $129.41 | General |
| Category: Heart Failure | ||||||
| 08/29/2024 | Merck Sharp & Dohme LLC | WINREVAIR (Biological) | Food and Beverage | In-kind items and services | $18.23 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/28/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $20.09 | General |
| Category: Heart Failure and Hypertension | ||||||
| 08/22/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $15.07 | General |
| 08/20/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $18.51 | General |
| Category: Cardiovascular | ||||||
| 08/20/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $13.88 | General |
| Category: Cardiovascular | ||||||
| 08/15/2024 | United Therapeutics Corporation | REMODULIN (Drug), ORENITRAM | Food and Beverage | In-kind items and services | $20.79 | General |
| Category: Pulmonary Arterial Hypertension | ||||||
| 08/14/2024 | AstraZeneca Pharmaceuticals LP | WAINUA (Drug) | Food and Beverage | In-kind items and services | $18.61 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/13/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $16.95 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/08/2024 | Bayer Healthcare Pharmaceuticals Inc. | Adempas (Drug) | Food and Beverage | In-kind items and services | $21.73 | General |
| Category: Cardio-pulmonary | ||||||
| 08/07/2024 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $19.83 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 07/24/2024 | AstraZeneca Pharmaceuticals LP | WAINUA (Drug) | Food and Beverage | In-kind items and services | $23.94 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 147 | 172 | $39,950 | $12,082 |
| 2022 | 2 | 41 | 75 | $19,035 | $5,264 |
All Medicare Procedures & Services
5 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 96 | 118 | $26,432 | $7,168 | 27.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 34 | 36 | $8,064 | $2,879 | 35.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 17 | 18 | $5,454 | $2,035 | 37.3% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 30 | 64 | $14,272 | $4,027 | 28.2% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 11 | 11 | $4,763 | $1,236 | 26.0% |
About Stephanie Short
Stephanie Short is a Acute Care healthcare provider based in Tulsa, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/18/2022. The National Provider Identifier (NPI) number assigned to this provider is 1780333724.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Stephanie Short has received a total of $3,415 in payments from pharmaceutical and medical device companies, with $1,038 received in 2024. These payments were reported across 152 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($3,402).
As a Medicare-enrolled provider, Short has provided services to 188 Medicare beneficiaries, totaling 247 services with total Medicare billing of $17,346. Data is available for 2 years (2022–2023), covering 5 distinct procedure/service records.
Practice Information
- Specialty Acute Care
- Location Tulsa, OK
- Active Since 03/18/2022
- Last Updated 03/18/2022
- Taxonomy Code 363LA2100X
- Entity Type Individual
- NPI Number 1780333724
Products in Payments
- LifeVest (Device) $381.92
- UPTRAVI (Drug) $303.37
- VERQUVO (Drug) $247.18
- OPSUMIT (Drug) $197.50
- JARDIANCE (Drug) $196.85
- LEQVIO (Drug) $184.73
- Adempas (Drug) $183.66
- WINREVAIR (Biological) $175.84
- TYVASO (Drug) $164.96
- AccuCinch (Device) $140.69
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) $129.41
- ONPATTRO (Drug) $115.73
- FARXIGA (Drug) $108.64
- WAINUA (Drug) $97.04
- CAMZYOS (Drug) $68.32
- VYNDAQEL (Drug) $60.96
- AMVUTTRA (Drug) $55.52
- ENTRESTO (Drug) $51.84
- Inpefa (Drug) $43.44
- REMODULIN (Drug) $43.10
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Acute Care Doctors in Tulsa
Pavel Buzadzhi
Acute Care — Payments: $16,980
Ganna Starkey, Aprn, APRN
Acute Care — Payments: $11,488
Christopher Gordon, Crnp, CRNP
Acute Care — Payments: $11,428
Jerrie Morales, Aprn, APRN
Acute Care — Payments: $10,500
Georgianne Tokarchik
Acute Care — Payments: $8,071
Kelli Leek
Acute Care — Payments: $8,033